首页> 外文期刊>Investigative ophthalmology & visual science >Polarized Expression of Monocarboxylate Transporters in Human Retinal Pigment Epithelium and ARPE-19 Cells.
【24h】

Polarized Expression of Monocarboxylate Transporters in Human Retinal Pigment Epithelium and ARPE-19 Cells.

机译:单羧酸盐转运蛋白在人视网膜色素上皮和ARPE-19细胞中的极化表达。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE. To evaluate the expression and subcellular distribution of proton-coupled monocarboxylate transporters (MCTs) in human RPE in vivo and determine whether ARPE-19 cells retain the ability to express and differentially polarize these transporters. METHODS. Total RNA was prepared from human donor eyes and from ARPE-19 cell cultures. Expression of MCT transcripts was evaluated by RT-PCR amplification. Expression of MCT proteins in human RPE and ARPE-19 cells was evaluated by immunolocalization and Western blot analysis with isoform-specific anti-peptide antibodies. RESULTS. The expression of MCTs in human RPE was investigated by immunofluorescence analysis on frozen sections of human donor eyes. MCT1 antibody labeled the apical membrane of the RPE intensely, whereas MCT3 labeling was restricted to the basolateral membrane. MCT4 was detected in the neural retina but not in the RPE. ARPE-19 cells constitutively expressed MCT1 and MCT4 mRNAs. Expression of MCT3 mRNA increased over time as ARPE-19 cells established a differentiated phenotype. Western blot analysis revealed that ARPE-19 cells expressed high levels of MCT1 and MCT4 but very little MCT3 protein. Sections of differentiated ARPE-19 cells were labeled with MCT1, MCT4, and glucose transporter-1 antibodies. MCT1 was polarized to the apical membrane and MCT4 to the basolateral membrane, whereas GLUT1 was expressed in both membrane domains. CD147, which is necessary for targeting MCTs to the plasma membrane, was detected in the apical and basolateral membranes of human RPE in situ and ARPE-19 cells. CONCLUSIONS. These studies demonstrate for the first time that human RPE expresses two proton-coupled monocarboxylate transporters: MCT1 in the apical membrane and MCT3 in the basolateral membrane. The coordinated activities of these two transporters could facilitate the flux of lactate from the retina to the choroid. ARPE-19 cells express two MCT isoforms, polarized to different membrane domains: MCT1 to the apical membrane and MCT4 to the basolateral membrane. The polarized expression of MCTs in ARPE-19 demonstrates that these cells retain the cellular machinery necessary for transepithelial transport of lactate.
机译:目的。若要评估质子偶联单羧酸盐转运蛋白(MCTs)在人RPE体内的表达和亚细胞分布,并确定ARPE-19细胞是否保留表达和差异极化这些转运蛋白的能力。方法。从人供体的眼睛和ARPE-19细胞培养物中制备总RNA。通过RT-PCR扩增评估MCT转录物的表达。 MCT蛋白在人RPE和ARPE-19细胞中的表达是通过免疫定位和用同工型特异性抗肽抗体进行的蛋白质印迹分析来评估的。结果。通过在人供体眼睛的冰冻切片上进行免疫荧光分析研究了MCT在人RPE中的表达。 MCT1抗体强烈标记RPE的顶膜,而MCT3标记仅限于基底外侧膜。在神经视网膜中检测到MCT4,但在RPE中未检测到。 ARPE-19细胞组成性表达MCT1和MCT4 mRNA。随着ARPE-19细胞建立分化表型,MCT3 mRNA的表达随时间增加。蛋白质印迹分析表明ARPE-19细胞表达高水平的MCT1和MCT4,但很少表达MCT3蛋白。分化的ARPE-19细胞的切片用MCT1,MCT4和葡萄糖转运蛋白1抗体标记。 MCT1极化到顶膜,MCT4极化到基底外侧膜,而GLUT1在两个膜域中表达。在人RPE原位和ARPE-19细胞的顶膜和基底外侧膜中检测到了将MCT靶向质膜所必需的CD147。结论。这些研究首次证明人RPE表达两种质子偶联的单羧酸盐转运蛋白:顶膜中的MCT1和基底外侧膜中的MCT3。这两个转运蛋白的协调活动可以促进乳酸从视网膜到脉络膜的通量。 ARPE-19细胞表达两种MCT亚型,极化到不同的膜结构域:MCT1到顶端膜,MCT4到基底外侧膜。 MCT在ARPE-19中的极化表达证明这些细胞保留了乳酸上皮运输所需的细胞机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号